Emerson Electric Co. (NYSE:EMR)

CAPS Rating: 5 out of 5

The Company designs and supplies product technology and delivers engineering services in a range of industrial, commercial and consumer markets.

Results 1 - 20 of 167 : 1 2 3 4 5 6 7 8 9 Next »

Recs

0
Member Avatar aerialist (< 20) Submitted: 4/26/2016 11:37:16 AM : Outperform Start Price: $55.79 EMR Score: -3.23

Free cash leader.

Recs

0
Member Avatar mballiet (43.22) Submitted: 4/20/2016 2:13:45 PM : Outperform Start Price: $55.14 EMR Score: -1.22

Better days ahead and a solid dividend while I wait.

Recs

0
Member Avatar gudabg (98.96) Submitted: 12/23/2015 1:54:30 AM : Outperform Start Price: $46.61 EMR Score: +13.52

Dividend Aristocrat with biggest yield

Recs

0
Member Avatar BYRDJD (< 20) Submitted: 10/29/2015 3:49:51 PM : Outperform Start Price: $46.24 EMR Score: +16.46

Beat down by the market news on manufacturing, the price is good. Dividend is almost 4% which though subject to interest rate risk, remains an above market rate.

Recs

0
Member Avatar ProcessEngineer (< 20) Submitted: 10/19/2015 12:25:58 AM : Underperform Start Price: $44.13 EMR Score: -18.82

Flashy EMR marketing is no longer sufficient to sell EMR technology. The sales is lagging due to low oil prices, but not only...

- The trumpeted EMR wireless transmitter solution is not delivering as promised - sales are disappointing.
- EMR technology has been rejected and disqualified by Petronas Malaysia in the RAPID project - a 26 billion dollar refining/petro-chemical investment - on the basis of a disqualified DeltaV SIS Charms safety solution . How will other giants in the regions react?
- The Chloride acquisition is a total failure
- EMR Network power division will be "released" to stand on its own, preventing integrated solutions against a strong HON and YEW.
- Useless acquisition of a reliability company (MRG) obliterating the added value being independent reliability advice. Who will trust the advice of an EMR company about an EMR company. Might as well let Volkswagen be in charge of exhaust testing.
After the big lay-offs go after the dividends?
Only one direction for this stock.

Recs

0
Member Avatar NikolaiVolkopf (72.96) Submitted: 9/24/2015 6:01:11 PM : Outperform Start Price: $43.11 EMR Score: +17.57

High yield dividend powerhouse.

Recs

0
Member Avatar 25fmc (< 20) Submitted: 9/1/2015 9:16:16 AM : Outperform Start Price: $44.06 EMR Score: +15.81

dividends

Recs

0
Member Avatar mrudolph72 (53.52) Submitted: 8/12/2015 2:22:02 AM : Outperform Start Price: $47.28 EMR Score: +13.09

historical valuation

Recs

0
Member Avatar 20for5 (68.21) Submitted: 8/11/2015 3:09:30 AM : Outperform Start Price: $48.05 EMR Score: +12.18

I'm watching a group of 20 stocks that are predominately priced at or below fair value based on historic valuations. The portfolio has an above average starting yield of about 3.35% compared to the S&P 500's 1.95%. The portfolio is designed to replicate something I might choose in retirement in order to live off of dividends alone instead of share harvesting and was inspired by a series of articles by Chuck Carnevale. My goal is to not make any changes for at least 5 years unless a dividend is frozen, cut or, I see a golden opportunity that increases current income as well as offers a better than average chance at capital appreciation. The portfolio doesn't need to necessarily beat the market for me to be satisfied with it's performance but I expect it to competitive in both short and longer time horizons as well as generate a rising income stream.

See ya in 2020.

Recs

0
Member Avatar gonelong (54.11) Submitted: 6/18/2015 3:59:59 PM : Outperform Start Price: $57.03 EMR Score: -3.46

DG50: http://seekingalpha.com/article/2764265-its-new-its-nifty-its-the-dividend-growth-50

Recs

0
Member Avatar silvertrader1974 (59.11) Submitted: 4/28/2015 2:45:31 PM : Outperform Start Price: $56.49 EMR Score: -3.27

Decades of dividend increases, big stock buy back. Solid company with a great balance sheet, What more do you want?

Recs

0
Member Avatar LovinMe (34.63) Submitted: 2/20/2015 12:00:49 AM : Outperform Start Price: $56.37 EMR Score: -3.86

Dividend Growth Stock. My favorite kind of stock.

Recs

0
Member Avatar huddaman (98.29) Submitted: 12/29/2014 1:57:34 PM : Outperform Start Price: $59.83 EMR Score: -9.66

M* Wide Moat addition, nothing fancy. Trailing adj PE 16.60, which is lower than 19.78 exactly a year ago, while Adj EPS grew from 3.55 to 3.77 (I know, so exciting) plus 3% dividend yield to boot.

Recs

0
Member Avatar afewgoodstocks14 (< 20) Submitted: 5/16/2014 2:30:12 PM : Outperform Start Price: $60.20 EMR Score: -24.96

Div. (Yield) $1.72 (2.6%)

Recs

0
Member Avatar danapu2000 (38.13) Submitted: 3/25/2014 1:35:05 PM : Outperform Start Price: $61.97 EMR Score: -24.50

Price cross ma50

Recs

0
Member Avatar afewgoodstocks11 (24.30) Submitted: 1/9/2014 7:40:40 AM : Outperform Start Price: $37.01 EMR Score: -36.05

Div. (Yield) $1.72 (2.5%)
Current Yield . . . . . . 4.32%

Recs

0
Member Avatar NechesInvst (99.61) Submitted: 12/7/2013 5:50:55 PM : Outperform Start Price: $62.57 EMR Score: -28.27

Looking at creating a Dividend/Income Portfolio.
Let's see how this works out.

Recs

0
Member Avatar 2win (< 20) Submitted: 12/2/2013 8:41:51 AM : Outperform Start Price: $62.29 EMR Score: -28.13

http://www.hendershotinvestments.com/new/hendershotinvestments/

Recs

0
Member Avatar drblanton (70.87) Submitted: 8/9/2013 4:26:24 AM : Outperform Start Price: $57.13 EMR Score: -28.14

So far, so good. I think EMR can continue the good work.

Recs

0
Member Avatar Teacherman333 (96.39) Submitted: 5/19/2013 1:22:32 PM : Outperform Start Price: $52.76 EMR Score: -25.18

For reference point and to allow for comments by others. As of the end of March, 2013.

ROE 19.98%
Trailing PE 21.04
PB 3.97
Div yield 2.80%

Featured Broker Partners